earnings

NASDAQ · AVIR
Atea Pharmaceuticals, Inc.
Healthcare · Biotechnology
$4.11
Down-$0.20 (-4.64%)
Updated Oct 31, 2026, 9:04 AM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 250M
- P/E ratio
- -1.97
- Dividend yield
- 0.00%
- 52-week range
- $2.87 – $6.45
- Volume
- 349.86K
- Avg. volume
- 399.61K
Price performance · AVIR
AVIR price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 29, 2026
AVIR closed at $4.31 after 21 trading sessions, down 15.49% for the selected period.
- Last close
- $4.31
- Period change
- -15.49%
- Period low
- $4.04
- Period high
- $5.16
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 29, 2026 | $4.30 | $4.50 | $4.26 | $4.31 | 280.88K |
| Oct 28, 2026 | $4.15 | $4.27 | $4.14 | $4.27 | 328.42K |
| Oct 27, 2026 | $4.14 | $4.2899 | $4.05 | $4.17 | 245.24K |
| Oct 26, 2026 | $4.04 | $4.24 | $3.94 | $4.16 | 251.09K |
| Oct 23, 2026 | $4.03 | $4.11 | $3.93 | $4.04 | 245.44K |
| Oct 22, 2026 | $4.08 | $4.17 | $4.02 | $4.05 | 318.76K |
| Oct 21, 2026 | $4.47 | $4.47 | $4.05 | $4.08 | 465.23K |
| Oct 20, 2026 | $4.34 | $4.58 | $4.315 | $4.465 | 288.83K |
| Oct 19, 2026 | $4.34 | $4.42 | $4.17 | $4.39 | 390.04K |
| Oct 16, 2026 | $4.54 | $4.55 | $4.30 | $4.32 | 345.88K |
| Oct 15, 2026 | $4.64 | $4.805 | $4.48 | $4.53 | 319.37K |
| Oct 14, 2026 | $4.92 | $4.92 | $4.60 | $4.63 | 414.46K |
| Oct 13, 2026 | $5.03 | $5.04 | $4.87 | $4.98 | 303.23K |
| Oct 12, 2026 | $5.13 | $5.20 | $5.03 | $5.03 | 190.7K |
| Oct 9, 2026 | $5.15 | $5.23 | $5.09 | $5.15 | 157.97K |
| Oct 8, 2026 | $4.98 | $5.23 | $4.91 | $5.155 | 350.92K |
| Oct 7, 2026 | $5.02 | $5.23 | $4.99 | $5.01 | 264.77K |
| Oct 6, 2026 | $5.16 | $5.19 | $4.98 | $5.07 | 229.37K |
| Oct 5, 2026 | $5.12 | $5.18 | $4.945 | $5.13 | 293.61K |
| Oct 2, 2026 | $5.16 | $5.215 | $5.05 | $5.13 | 253.26K |
| Oct 1, 2026 | $5.16 | $5.20 | $4.93 | $5.10 | 408.66K |
Latest AVIR news
The latest Smart Investors Daily articles mentioning AVIR.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…

